Afoxolaner

Specifications

1093861-60-9CAS Number

832-051-7EC Number

4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamideIUPAC Name

C26H17ClF9N3O3Chemical Formula

625.9 g/molMolecular Weight

Afoxolaner; 1093861-60-9; NEXGARD; 02L07H6D0U; DTXSID50148921; NEXGARD SPECTRA CONPONENT AFOXOLANER; 1-Naphthalenecarboxamide, 4-(5-(3-chloro-5-(trifluoromethyl)phenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl)-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)-; afoxolanerum; RefChem:56645; DTXCID301767818; 4-(5-(3-chloro-5-(trifluoromethyl)-phenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl)-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl-1-naphthalenecarboxamide; A1443; 4-(5-(3-Chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)-1-naphthamide; UNII-02L07H6D0U; 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide; 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide; Afoxolaner [USAN]; Afoxolaner [USAN:INN]; C26H17ClF9N3O3; Afoxolaner?; 4-[5-[3-Chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide; 4-[5-(3-chloro-5-trifluoromethylphenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-naphthalene-1-carboxylic acid [(2,2,2-trifluoroethylcarbamoyl)-methyl]-amide; Afoxolaner; Nexgard; AFOXOLANER [MI]; AFOXOLANER [INN]; Afoxolaner (USAN/INN); SCHEMBL119580; orb1308871; orb3025943; AFOXOLANER [GREEN BOOK]; CHEMBL2219412; SCHEMBL29358921; SCHEMBL29367347; GLXC-20713; EX-A3267; MSK25118; MFCD30533411; AKOS040740686; AFOXOLANER [EMA EPAR VETERINARY]; Afoxolaner 100 microg/mL in Acetonitrile; DA-50258; FA104290; HY-16974; MS-30823; CS-0013215; AFOXOLANER CONPONENT OF NEXGARD SPECTRA; D10361; G15956; T13536; Q21051346; 1-NAPHTHALENECARBOXAMIDE, 4-(5-(3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-4,5-DIHYDRO-5- (TRIFLUOROMETHYL)-3-ISOXAZOLYL)-N-(2-OXO-2-((2,2,2-TRIFLUOROETHYL)AMINO)ETHYL)-; 4-(5-(3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-YL(-N- (2-OXO-2-((2,2,2-TRIFLUOROETHYL)AMINO)ETHYL(NAPHTHALENE-1-CARBOXAMIDE; 4-(5-(3-Chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)naphthalene-1-carboxamide; 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide; 4-{5-[3-Chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl}-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}naphthalene-1-carboxamideSynonyms